Complement system activation through the alternative pathway associates with disseminated intravascular coagulation to increase mortality in sepsis

IF 3.4 3区 医学 Q1 HEMATOLOGY Thrombosis research Pub Date : 2025-02-04 DOI:10.1016/j.thromres.2025.109281
Tomohiro Abe , Katsutoshi Saito , Takehiko Nagano , Yusuke Yamada , Hidenobu Ochiai
{"title":"Complement system activation through the alternative pathway associates with disseminated intravascular coagulation to increase mortality in sepsis","authors":"Tomohiro Abe ,&nbsp;Katsutoshi Saito ,&nbsp;Takehiko Nagano ,&nbsp;Yusuke Yamada ,&nbsp;Hidenobu Ochiai","doi":"10.1016/j.thromres.2025.109281","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Sepsis-induced disseminated intravascular coagulation (DIC) increases mortality in sepsis patients. Complement system activation is concomitant with sepsis-induced DIC; however, it is unclear how these two pathologies influence clinical parameters of sepsis individually and in combination, and which of the complement pathways activation is predominantly associated with mortality.</div></div><div><h3>Methods</h3><div>In this ancillary analysis of a prospective observational study, 49 adult sepsis patients were assigned to four groups according to the absence/presence of DIC and complement activation. Effects of complement activation and DIC on clinical demographics including parameters of DIC, systemic severities, and 60-days all-cause mortality were assessed by comparing the groups. We analyzed each complement pathway by comparing Bb, C3a/C3 ratio, SC5b-9/C3 ratio, C4d, C4d/C4 ratio, C3a, C5a, and SC5b-9 between survivors/non-survivors both in all the patients and in the DIC+ subgroup.</div></div><div><h3>Results</h3><div>Complement system activation induced thrombocytopenia and enhanced sepsis severity measured as APACHE2 and SOFA scores. 60-days all-cause mortality was different between groups, with 0 % in the complement activation alone group, 14 % in the DIC alone group and 66 % in the combined DIC and complement activation group. Bb and C3a/C3 and SC5b-9/C3 ratios were higher in non-survivors, with Bb and SC5b-9/C3 ratio still higher in DIC+ non-survivors.</div></div><div><h3>Conclusion</h3><div>Complement activation worsen the severity of sepsis and cause thrombocytopenia. Co-occurrence of complement activation and DIC increased sepsis mortality. The alternative pathway of complement activation plays a major role in sepsis mortality.</div></div>","PeriodicalId":23064,"journal":{"name":"Thrombosis research","volume":"247 ","pages":"Article 109281"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thrombosis research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0049384825000301","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Sepsis-induced disseminated intravascular coagulation (DIC) increases mortality in sepsis patients. Complement system activation is concomitant with sepsis-induced DIC; however, it is unclear how these two pathologies influence clinical parameters of sepsis individually and in combination, and which of the complement pathways activation is predominantly associated with mortality.

Methods

In this ancillary analysis of a prospective observational study, 49 adult sepsis patients were assigned to four groups according to the absence/presence of DIC and complement activation. Effects of complement activation and DIC on clinical demographics including parameters of DIC, systemic severities, and 60-days all-cause mortality were assessed by comparing the groups. We analyzed each complement pathway by comparing Bb, C3a/C3 ratio, SC5b-9/C3 ratio, C4d, C4d/C4 ratio, C3a, C5a, and SC5b-9 between survivors/non-survivors both in all the patients and in the DIC+ subgroup.

Results

Complement system activation induced thrombocytopenia and enhanced sepsis severity measured as APACHE2 and SOFA scores. 60-days all-cause mortality was different between groups, with 0 % in the complement activation alone group, 14 % in the DIC alone group and 66 % in the combined DIC and complement activation group. Bb and C3a/C3 and SC5b-9/C3 ratios were higher in non-survivors, with Bb and SC5b-9/C3 ratio still higher in DIC+ non-survivors.

Conclusion

Complement activation worsen the severity of sepsis and cause thrombocytopenia. Co-occurrence of complement activation and DIC increased sepsis mortality. The alternative pathway of complement activation plays a major role in sepsis mortality.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
补体系统激活通过替代途径与弥散性血管内凝血相关,增加败血症的死亡率
脓毒症诱导的弥散性血管内凝血(DIC)增加脓毒症患者的死亡率。补体系统激活伴随脓毒症引起的DIC;然而,目前尚不清楚这两种病理如何单独或联合影响败血症的临床参数,以及哪一种补体途径的激活与死亡率主要相关。方法在一项前瞻性观察性研究的辅助分析中,49例成年脓毒症患者根据有无DIC和补体激活分为四组。补体激活和DIC对临床人口学的影响,包括DIC参数、全身严重程度和60天全因死亡率。我们通过比较所有患者和DIC+亚组幸存者/非幸存者之间的Bb、C3a/C3比值、SC5b-9/C3比值、C4d、C4d/C4比值、C3a、C5a和SC5b-9来分析每种补体通路。结果补体系统激活诱导血小板减少,加重脓毒症严重程度,以APACHE2和SOFA评分衡量。60天全因死亡率组间差异较大,补体单独激活组为0%,DIC单独激活组为14%,DIC和补体联合激活组为66%。非幸存者中Bb、C3a/C3和SC5b-9/C3比值较高,DIC+非幸存者中Bb、SC5b-9/C3比值更高。结论补体活化加重脓毒症的严重程度,引起血小板减少。补体活化和DIC的共存增加了败血症死亡率。补体激活的替代途径在败血症死亡率中起主要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thrombosis research
Thrombosis research 医学-外周血管病
CiteScore
14.60
自引率
4.00%
发文量
364
审稿时长
31 days
期刊介绍: Thrombosis Research is an international journal dedicated to the swift dissemination of new information on thrombosis, hemostasis, and vascular biology, aimed at advancing both science and clinical care. The journal publishes peer-reviewed original research, reviews, editorials, opinions, and critiques, covering both basic and clinical studies. Priority is given to research that promises novel approaches in the diagnosis, therapy, prognosis, and prevention of thrombotic and hemorrhagic diseases.
期刊最新文献
Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial. Implementation of institutional thrombophilia guidelines and electronic medical record tools to reduce inpatient thrombophilia testing and costs. Letter to the editor: Methodological considerations for diagnostic test accuracy meta-analyses. Barriers and facilitators to healthy lifestyle behaviours for people living with post pulmonary embolism syndrome. A qualitative study exploring participants lived experiences. Obesity and type 2 diabetes mellitus add up to induce platelet hyperreactivity and platelet activation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1